Tech Channel Mongolia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Channel Mongolia.

Press releases published on March 30, 2026

Mar. 30, 2026

MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue

Indeterminate GlobeNewswire

Mar. 30, 2026

WISeKey’s WISeSat.Space Subsidiary Successfully Launches Its 21st Satellite to Low Earth Orbit with SpaceX

Indeterminate GlobeNewswire

Mar. 30, 2026

Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment

Indeterminate GlobeNewswire

Mar. 30, 2026

Anavex Life Sciences Provides Comprehensive Regulatory Update

Indeterminate GlobeNewswire

Mar. 30, 2026

Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Indeterminate GlobeNewswire

Mar. 30, 2026

Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate

Indeterminate GlobeNewswire

Mar. 30, 2026

BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder

Indeterminate GlobeNewswire

Mar. 30, 2026

BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9

Indeterminate GlobeNewswire

Mar. 30, 2026

FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

Indeterminate GlobeNewswire

Mar. 30, 2026

BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026

Indeterminate GlobeNewswire

Mar. 30, 2026

InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting

Indeterminate GlobeNewswire

Mar. 30, 2026

SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026

Indeterminate GlobeNewswire

Mar. 30, 2026

Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program

Indeterminate GlobeNewswire

Mar. 30, 2026

Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026

Indeterminate GlobeNewswire

Mar. 30, 2026

Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan

Indeterminate GlobeNewswire

Mar. 30, 2026

Connect Biopharma Announces $20.2 Million Private Placement Financing

Indeterminate GlobeNewswire

Mar. 30, 2026

Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study

Indeterminate GlobeNewswire

Mar. 30, 2026

Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered

Indeterminate GlobeNewswire

Mar. 30, 2026

Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Mar. 30, 2026

Full Market Visibility Is Crucial for Winning Deals: What PE Firms Need to Know Now

Indeterminate GlobeNewswire